Richard Beasley

58.0k total citations · 15 hit papers
596 papers, 34.9k citations indexed

About

Richard Beasley is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Richard Beasley has authored 596 papers receiving a total of 34.9k indexed citations (citations by other indexed papers that have themselves been cited), including 301 papers in Pulmonary and Respiratory Medicine, 300 papers in Physiology and 60 papers in Epidemiology. Recurrent topics in Richard Beasley's work include Asthma and respiratory diseases (291 papers), Respiratory and Cough-Related Research (147 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (101 papers). Richard Beasley is often cited by papers focused on Asthma and respiratory diseases (291 papers), Respiratory and Cough-Related Research (147 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (101 papers). Richard Beasley collaborates with scholars based in New Zealand, United Kingdom and Australia. Richard Beasley's co-authors include Neil Pearce, Mark Weatherall, Julian Crane, Matthew Masoli, Shaun Holt, Denise Fabian, Stephen T. Holgate, Ulrich Keil, Edwin A. Mitchell and Sarah Aldington and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard Beasley

566 papers receiving 33.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods

1995 2.9k citations Richard Beasley, Neil Pearce et al. European Respiratory Journal profile →
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC

1998 2.7k citations Richard Beasley profile →
The global burden of asthma: executive summary of the GINA Dissemination Committee Report

2004 2.6k citations Richard Beasley et al. profile →
Mucosal Inflammation in Asthma

1990 1.1k citations Richard Beasley et al. profile →
Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

2007 914 citations Neil Pearce, Richard Beasley et al. Thorax profile →
Cellular Events in the Bronchi in Mild Asthma and after Bronchial Provocation

1989 903 citations Richard Beasley et al. profile →
SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS

1989 898 citations Richard Beasley et al. profile →
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

2004 839 citations Richard Beasley et al. profile →
Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)

2009 768 citations Richard Beasley et al. Thorax profile →
Treatable traits: toward precision medicine of chronic airway diseases

2016 653 citations Àlvar Agustí, Elisabeth H. Bel et al. European Respiratory Journal profile →
Epidemiology and costs of chronic obstructive pulmonary disease

2005 543 citations P. Vermeire, A. Sonia Buist et al. European Respiratory Journal profile →
PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY

1989 440 citations Neil Pearce, Richard Beasley et al. profile →
Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit

2015 414 citations Paul J. Young, Michael Bailey et al. profile →
Risk factors for asthma: is prevention possible?

2015 366 citations Richard Beasley, Edwin A. Mitchell et al. profile →
Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

2019 266 citations Richard Beasley, Mark Holliday et al. profile →

Peers

Countries citing papers authored by Richard Beasley

Since Specialization

Citations

This map shows the geographic impact of Richard Beasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Beasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Beasley more than expected).

Fields of papers citing papers by Richard Beasley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Beasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Beasley. The network helps show where Richard Beasley may publish in the future.

Co-authorship network of co-authors of Richard Beasley

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Beasley. A scholar is included among the top collaborators of Richard Beasley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Beasley. Richard Beasley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Alberto Papi, Richard Beasley, Elliot Israel, Reynold A. Panettieri, Frank C. Albers, Mark E. Cooper, (unknown), Ileen Gilbert, Frank Trudo, Mark Weinberg, (unknown)	0
2	Patterns of Asthma Medication Use in New Zealand After Publication of National Asthma Guidelines 2023 ·The Journal of Allergy and Clinical Immunology In Practice ·Lee Hatter, Allie Eathorne, Thomas Hills, Pepa Bruce, Claire Houghton, Mark Weatherall, Richard Beasley	9
3	The treatable traits approach to adults with obstructive airways disease in primary and secondary care 2023 ·Respirology ·Mike Thomas, Richard Beasley	7
4	Engineering Complicated Systems Still Needs Systems Engineering and Thinking 2022 ·INCOSE International Symposium ·Andrew C Pickard, Richard Beasley	1
5	Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: a randomised crossover trial 2022 ·European Respiratory Journal ·Nethmi Kearns, Pepa Bruce, Mathew Williams, (unknown), (unknown), Mark Weatherall, Richard Beasley	4
6	Social Science Solutions for the Systems Engineer: What's Needed 2021 ·INCOSE International Symposium ·(unknown), Richard Beasley, (unknown)	1
7	Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort 2021 ·European Respiratory Journal ·Helen K. Reddel, Jørgen Vestbo, Àlvar Agustí, Gary P. Anderson, Aruna T. Bansal, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry J. Make, Ian Pavord, David Price, Eleni Rapsomaniki, Niklas Karlsson, Donna K. Finch, Javier Nuevo, (unknown), Marianna Alacqua, Rod Hughes, Hana Müllerová, Maria Gerhardsson de Verdier, (unknown)	44
8	The management of mild asthma 2020 ·European Respiratory Journal ·Paul M. O’Byrne, Helen K. Reddel, Richard Beasley	15
9	Towards a personalised treatment approach for asthma attacks 2020 ·Thorax ·Matthew Martin, Richard Beasley, Tim Harrison	14
10	The history and future of short‐acting beta₂‐agonist therapy in asthma 2019 ·Respirology ·Thomas Hills, Richard Beasley	6
11	Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial 2018 ·BMC Pulmonary Medicine ·George Bardsley, Janine Pilcher, Steven McKinstry, Philippa Shirtcliffe, James Berry, James Fingleton, Mark Weatherall, Richard Beasley	20
12	Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma 2017 ·BMJ Open Respiratory Research ·James Fingleton, Jo Hardy, Christina Baggott, Janine Pilcher, Andrew Corin, (unknown), Matire Harwood, Mark Holliday, Helen K. Reddel, Philippa Shirtcliffe, (unknown), Mark Weatherall, Richard Beasley	13
13	Pilot study of feasibility of a randomised controlled trial of asthma risk with paracetamol versus ibuprofen use in infancy. 2016 ·PubMed ·(unknown), Anna Hunt, (unknown), (unknown), Irene Braithwaite, Mark Weatherall, Thorsten Stanley, Richard Beasley, Edwin A. Mitchell, Stuart R. Dalziel	2
14	Oxygenation targets and monitoring in the critically ill: a point prevalence study of clinical practice in Australia and New Zealand 2015 ·Critical Care and Resuscitation ·Paul J. Young, Richard Beasley, Gilles Capellier, Glenn M. Eastwood, Steve Webb	2
15	Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program 2015 ·Critical Care and Resuscitation ·Sumeet Reddy, Paul J. Young, Richard Beasley, Diane Mackle, Shay McGuinness, Colin McArthur, Seton Henderson, Laurence Weinberg, Craig French, Neil Orford, Michael Bailey, Rinaldo Bellomo	12
16	Venous thromboembolism rates in patients with lower limb immobilization after Achilles tendon injury are unchanged after the introduction of prophylactic aspirin: audit 2015 ·Journal of Thrombosis and Haemostasis ·Irene Braithwaite, L. A. Dunbar, Allie Eathorne, Mark Weatherall, Richard Beasley	9
17	A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study 2014 ·Critical Care and Resuscitation ·Sumeet Reddy, Michael Bailey, Richard Beasley, Rinaldo Bellomo, Seton Henderson, Diane Mackle, Colin McArthur, Jan Mehrtens, John Myburgh, Shay McGuinness, Alex Psirides, Paul J. Young	15
18	Phenotyping airways disease by cluster analysis in primary care: 6 distinct clusters identified 2014 ·European Respiratory Journal ·Janwillem Kocks, Mark Weatherall, Esther Metting, R.A. Riemersma, James Fingleton, Thys van der Molen, Richard Beasley	1
19	The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection 2012 ·Critical Care and Resuscitation ·Paul J. Young, Manoj Saxena, Rinaldo Bellomo, Ross Freebairn, Naomi Hammond, Frank van Haren, Seton Henderson, Colin McArthur, Shay McGuinness, Diane Mackle, John Myburgh, Mark Weatherall, Steve Webb, Richard Beasley	13
20	Asthma mortality:summary of a round-table discussion, New York, January 1997 1999 ·European Respiratory Journal ·Ursula Ackermann‐Liebrich, H Ross Anderson, Josep M. Antó, Richard Beasley, A. Sonia Buist, Peter Burney, Pierre Ernst, Peter J. Gergen, Richard Ingram, Stephan Lanes, Neil Pearce, C.E. Reed, B Rijcken, Samy Suissa, P. Vermeire, Alexander M. Walker, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact